title: Metabolic activation of chlorpromazine by stimulated human polymorphonuclear leukocytes. Induction of covalent binding of chlorpromazine to nucleic acids and proteins.
abstract: Human polymorphonuclear leukocytes (PMNs) have been stimulated with either phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187 or a combination of both to induce the respiratory burst and myeloperoxidase (MPO) release. Chlorpromazine (CPZ) but not chlorpromazine sulfoxide (CPZSO) inhibited the respiratory burst as measured with lucigenin chemiluminescence. The inhibition was due to interference with processes in the cell leading to the respiratory burst and not to scavenging of produced oxygen radicals that provoke the luminescence. CPZ was metabolized by stimulated PMNs. HPLC analysis revealed formation of CPZSO and an unidentified product. Both products result from decay of chlorpromazine radical cation (CPZ+.), indicating formation of this radical intermediate in CPZSO oxidation by stimulated PMNs. CPZ conversion correlated with H2O2 production and MPO release. The largest CPZ conversion was observed with phorbol ester plus A23187 stimulation. The conversion was reduced by catalase and sodium azide, an inhibitor of MPO, with 70% and 40%, respectively. This indicates only partial involvement of extracellularly released MPO in CPZ metabolism by PMNs. Considerable covalent binding of [3H]CPZ to nucleic acids and proteins of intact stimulated PMNs was observed. This binding was larger upon co-stimulation with phorbol ester and A23187. Azide did not reduce covalent binding. This indicates that covalent binding is not mediated by extracellularly released MPO and that CPZ is probably activated intracellularly. Activation of PMNs and production of H2O2 is a prerequisite for both CPZ conversion and covalent binding. This study demonstrates that phagocytic cells might contribute to drug metabolism and drug-induced toxicity.
authors.affiliation: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Utrecht University, The Netherlands.
authors.forename: P P
authors.initials: PP
authors.lastname: Kelder
authors.forename: N J
authors.initials: NJ
authors.lastname: de Mol
authors.forename: B A
authors.initials: BA
authors.lastname: 'T Hart
authors.forename: L H
authors.initials: LH
authors.lastname: Janssen
mesh_terms: D001711:Biotransformation; D000001:Calcimycin / Q000494:pharmacology; D002746:Chlorpromazine / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004249:DNA Damage; D006801:Humans; D066298:In Vitro Techniques; D008163:Luminescent Measurements; D009504:Neutrophils / Q000378:metabolism*; D009696:Nucleic Acids / Q000378:metabolism*; D009195:Peroxidase / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D009696:Nucleic Acids; D011506:Proteins; D000001:Calcimycin; D009195:Peroxidase; D013755:Tetradecanoylphorbol Acetate; D002746:Chlorpromazine